<DOC>
	<DOCNO>NCT00042068</DOCNO>
	<brief_summary>A 12-week trial consist 5 visit ( 6 follow need ) find effective safe three different dos meloxicam compare placebo Rheumatoid Arthritis . Patient take one dose study medication daily .</brief_summary>
	<brief_title>A Multi-Center Trial Compare Three Doses Meloxicam Placebo Patients With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Meloxicam</mesh_term>
	<criteria>Age great equal 18 less equal 80 Diagnosis Rheumatoid Arthritis least six week Taking NSAID If female : use adequate contraception Willingness stop current NSAID criterion reach begin study drug Able provide write informed consent Intolerance hypersensitivity NSAIDs ingredients trial drug Pregnancy , lactate Use investigational drug within 30 day prior enter trial History peptic ulcer gastrointestinal hemorrhage except simple hemorrhoidal bleed History cerebrovascular bleeding disorder Severe hypertension Other disease might interfere safety patient evaluation trial drug ( investigator 's opinion ) RA functional class IV Synovectomy large joint within past 6 month prior enter trial plan trial Concomitant therapy anticoagulant , therapeutic dos aspirin , phenothiazine , lithium , chronic GImedication , analgesic drug ( except acetaminophen 4 grams/day ) DMARDs initiate within past three month dose change less two month enter trial Therapy corticosteroid exceed 10 mg/day prednisone equivalent change dose within 1 month trial Concomitant therapy ACTH within past month enter trial . History narcotic alcohol abuse ( past 12 month ) Abnormal laboratory value Previous participation present trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>